Spatial biology promises unprecedented insight into biology and disease – but is the field living up to its potential?
In this in-depth conversation, Dr Yuliia Shymko sit down with Giovanni Russo (Gio) to explore what’s truly holding spatial biology back. From the long-standing tension between academia and industry to persistent challenges in software, data interpretation, and training, this discussion goes beyond the hype to examine why clinical adoption remains so difficult.
Gio brings a rare cross-functional perspective, drawing on experience across research, field service, sales, and commercialization. Together, we unpack where spatial technologies are delivering real value today, which platforms are closest to clinical impact, and what must change over the next five years for the field to move forward.
Topics covered in our Spatial Biology talk include:
- Why spatial isn’t new – and why it’s treated like it is
- Academia vs. industry: barriers to commercialization
- Software and data analysis as the true bottlenecks
- Training bias and misinterpretation of complex datasets
- Why most spatial technologies stay in academia
- Revenue drivers, sales challenges, and real-world adoption
- What actually makes spatial worth the hype
Watch the full conversation here:
Subscribe for more discussions on spatial biology, biotech, and life sciences
